TERT and neoplasm: Because tumor-specific oncolytic adenovirus can amplify many times in infected cancer cells and dissolve them, a TERT promoter driven CRAd was regarded to be the most widely targeting tumor (90% of tumor) and a more potent replicating CRAd [11].